FibroBiologics announces three US patents for fibroblast technology

FibroBiologics, Inc.

Patent 11,717,596 (Sevrain): Methods for cartilage repair using in vivo bioreactor.
Patent 11,732,239 (O'Heeron): Treatment of disc degenerative disease with fibroblast conditioned media.
Patent 11,819,555 (O'Heeron): Gene therapy for regeneration of chondrocytes or cartilage-type cells.
Company now holds 150+ patents issued and pending, reinforcing its IP portfolio.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.